Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $73.53 USD
Change Today -0.28 / -0.38%
Volume 6.7M
MDT On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 4:15 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher James O'Connell

Former Executive Vice President and Group President of Restorative Therapies, Medtronic plc
AgeTotal Calculated CompensationThis person is connected to 45 board members in 1 different organizations across 3 different industries.

See Board Relationships
48$3,785,854
As of Fiscal Year 2014

Background*

Mr. Christopher James O'Connell, also known as Chris, served as an Executive Vice President and Group President of Restorative Therapies Group at Medtronic plc from January 2015 to June 2015. Mr. O'Connell has global responsibility for Medtronic’s Spine and Biologics, Neuromodulation, Surgical Technologies and Orthopedics business units. Mr. O'Connell provides overall strategic direction and global operational oversight for this group of related businesses, as well as ...

Read Full Background

Corporate Headquarters*

20 On Hatch
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 438 1700
Fax: --

Board Members Memberships*

Director
2012-2013
Former Non-Executive Director

Education*

MBA 1994
Harvard University
Bachelor's Degree 1989
Northwestern University

Other Affiliations*

Annual Compensation*

Salary$675,135
Total Annual Compensation$675,135

Stock Options*

Restricted Stock Awards$833,009
All Other Compensation$35,340
Exercised Options32,411
Exercised Options Value$229,834
Exercisable Options299,206
Exercisable Options Value$5,192,615
Unexercisable Options180,298
Unexercisable Options Value$2,656,066
Total Value of Options$8,078,515
Total Number of Options511,915

Total Compensation*

Total Annual Cash Compensation$1,973,268
Total Short Term Compensation$675,135
Other Long Term Compensation$868,349
Total Calculated Compensation$3,785,854
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $73.53 USD -0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.